NasdaqGS - Delayed Quote USD
Prelude Therapeutics Incorporated (PRLD)
1.0000
+0.1173
+(13.29%)
At close: May 13 at 4:00:01 PM EDT
1.0000
0.00
(0.00%)
After hours: May 13 at 7:04:55 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-105,328
-102,888
-107,063
-83,729
-83,531
Investing Cash Flow
121,156
90,191
-34,646
81,691
-263,803
Financing Cash Flow
-266
-120
136,395
815
164,897
End Cash Position
44,313
16,518
29,335
34,649
35,872
Capital Expenditure
-522
-764
-3,513
-3,019
-2,323
Issuance of Capital Stock
0
0
135,731
0
161,424
Repayment of Debt
-550
-395
0
--
0
Free Cash Flow
-105,850
-103,652
-110,576
-86,748
-85,854
12/31/2021 - 9/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FHTX Foghorn Therapeutics Inc.
4.3300
-2.26%
STTK Shattuck Labs, Inc.
0.9606
-3.07%
KYMR Kymera Therapeutics, Inc.
31.14
-3.20%
CGEM Cullinan Therapeutics, Inc.
7.62
-3.67%
NRIX Nurix Therapeutics, Inc.
9.73
-4.42%
RAPP Rapport Therapeutics, Inc.
9.99
-4.58%
LYEL Lyell Immunopharma, Inc.
0.4046
-4.03%
NXTC NextCure, Inc.
0.4485
+3.27%
INCY Incyte Corporation
60.81
-0.07%
ALXO ALX Oncology Holdings Inc.
0.4810
+10.52%